Qualitative amplification test of DNA for second-generation high-risk human papillomavirus DNA - Taiwan Registration 001c28b19f8cfb17fb8d472ca576374f
Access comprehensive regulatory information for Qualitative amplification test of DNA for second-generation high-risk human papillomavirus DNA in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 001c28b19f8cfb17fb8d472ca576374f and manufactured by QIAGEN GAITHERSBURG, INC.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Nucleic acid hybridization analysis uses a signal-amplified microdisk chemical cold light to qualitatively detect 13 high-risk types of human papillomavirus (HPV) DNA in the cervix.
C Immunology and microbiology
C.0004 Human papillomavirus serum reagent
import
Dates and Status
May 13, 2005
May 13, 2015
May 17, 2018
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ